Desk›Healthcare› Molbio Diagnostics Ltd
Molbio Diagnostics Ltd
BSE 544866 · NSE MOLBIO · ISIN INE869T01028 · Group B · Active
Healthcare › Healthcare › Healthcare Equipment & Supplies › Medical Equipment & Supplies
₹1,097.40
-4.19%
BSE close, 28 August 2026
₹12,646.44 cr
11.5 cr shares · Small cap
₹2,349.61 cr
as published
— · —
EPS — · BV —
—
no annual figures
19
2 selected · 11%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -13.0% |
|---|---|
| Against 52-week low | +18.5% |
| Day change | -4.19% |
| Size band | Small cap |
| Index membership | None |
Disclosure profile 19 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Investor Presentation | 1 |
| Press Release | 1 |
| Selected sub-total | 2 |
| Procedural | |
| SAST | 5 |
| Analyst / Investor Meet | 3 |
| Outcome | 2 |
| Trading Window | 2 |
| Board Meeting | 1 |
| Compliance Certificate | 1 |
| General | 1 |
| New Listing | 1 |
| Newspaper Publication | 1 |
| Procedural sub-total | 17 |
| Total | 19 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
19 filings · 2 selected · busiest 2026-09-25
Filing rhythm · the twelve most recent
2026-09-082026-10-08
SelectedProcedural
Filings
19 in the window
-
8 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of the SEBI(Depositories and Participants)Regulations, 2018 for the quarter ended September 30,2026.
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
1 October 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for India Business Excellence Fund III
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
1 October 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for India Business Excellence Fund III,
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
28 September 2026 ·
Closure of Trading Window
Intimation of Closure of Trading Window for the Quarter ended September 30,2026.
Insider Trading / SAST / Closure of Trading Window View filing →
-
25 September 2026 ·
Board Meeting Outcome for Re-Appointment Of Cost Auditor Of The Company For FY 2026-27.
Intimation of re-appointment of Cost Auditor of the Company pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.
Others / Outcome without intimation View filing →
-
25 September 2026 ·
Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for India Business Excellence Fund III
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
25 September 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for India Business Excellence Fund III
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
24 September 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for India Business Excellence Fund III
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
17 September 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Analysts/Investors Meeting under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, scheduled to be held on Tuesday, September ....
Company Update / Analyst / Investor Meet View filing →
-
9 September 2026 ·
Change Of Corporate Identification Number (CIN) Of The Company.
Intimation of Change of Corporate Identification Number (CIN) of the company.
Company Update / General View filing →
-
8 September 2026 ·
Analyst / Investor Meet - Outcome
Audio Recording of Earnings Call for the quarter ended June 30, 2026.
Company Update / Analyst / Investor Meet View filing →
-
8 September 2026 ·
Investor Presentation
Investor Presentation on Unaudited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2026.
Company Update / Investor Presentation View filing →
-
7 September 2026 ·
Newspaper Publication
Newspaper advertisments of Un-Audited Financials Results for the quarter ended June 30, 2026.
Company Update / Newspaper Publication View filing →
-
7 September 2026 ·
Press Release / Media Release
Molbio Diagnostics Limited has informed the Exchange regarding the Press Release for the Quarter ended June 30,2026.
Company Update / Press Release / Media Release View filing →
-
2 September 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Earnings Conference Call under Regulation 30 and all other applicable regulations, if any, of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) ....
Company Update / Analyst / Investor Meet View filing →
-
1 September 2026 ·
Board Meeting Intimation for To Consider And Approve The Financial Results For The Quarter Ended 30 June 2026.
Molbio Diagnostics Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2026 ,inter alia, to consider and approve To consider and approve ....
Board Meeting / Board Meeting View filing →
-
27 August 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting Held On August 27, 2026, As Per Reg 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations').
Outcome of Board Meeting held on August 27, 2026, as per Reg 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations').
Others / Outcome without intimation View filing →
-
20 August 2026 ·
Closure of Trading Window
Intimation of Closure Trading Window as per SEBI (Prohibition of Insider Trading) Regulations, 2015
Insider Trading / SAST / Closure of Trading Window View filing →
-
17 August 2026 ·
Listing of Equity Shares of Molbio Diagnostics Ltd
Trading Members of the Exchange are hereby informed that effective from August 17, 2026, the Equity Shares of Molbio Diagnostics Ltd (Scrip Code: 544866) are listed and admitted to dealings ....
New Listing / New Listing
RSS feed for Molbio Diagnostics Ltd · the 50 most recent filings